Advanced glycation endproducts (AGEs) in saliva of patients with multiple myeloma - a pilot study.

Abstract excerpt

Multiple myeloma (MM) is a hematological cancer with underlying causes associated with increased oxidative stress. Through signaling of their receptor RAGE, advanced glycation endproducts (AGEs) are known to increase oxidative stress associated with malignant transformation. In the present study, we have demonstrated that the levels of these compounds are increased in the saliva of myeloma patients with bone...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Glycation End Products, Advanced